Management of primary sclerosing cholangitis: Conventions and controversies, Pulsus Group Inc
CANADIAN JOURNAL OF GASTROENTEROLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)

Abstract

Note: (Optional)

Citation Builder

  •  
Return to Table of Contents
 
Reviews May 2012, Volume 26 Issue 5: 261-268
 

Management of primary sclerosing cholangitis: Conventions and controversies

N Chandok | GM Hirschfield

Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholangiopathy that results in fibrotic strictures and dilations of the intra- and extrahepatic bile ducts. PSC is uncommon, occurs predominantly in males and has a strong association with inflammatory bowel disease. While the pathogenesis of PSC has not been fully elucidated, emerging evidence supports roles for the innate and adaptive immune systems, and genome-wide analyses have identified several genetic associations. Using the best available evidence, the present review summarizes the current understanding of the diagnosis, pathogenesis and management of PSC. Despite its rarity, there is an urgent need for collaborative research efforts to advance therapeutic options for PSC beyond liver transplantation.

Diagnosis | Liver transplantation | Pathogenesis | Primary sclerosing cholangitis
   Français   
          
Click to download PDF Reader
 
 




Copyright © Pulsus Group Inc.